BBIO BridgeBio Pharma, Inc.
Nasdaq · SEC CIK 1743881 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $122.75M 41 sales by 10 insiders
- Filings on record
- 262 since 2021-08-06, latest 2026-09-21 18:21
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Kumar Neil | CEO, Dir | — | $61.54M |
| Cook Jennifer E. | Dir | — | $21.92M |
| MCCORMICK FRANK | Dir | — | $13.31M |
| Lo Andrew | Dir | — | $6.32M |
| Ellis Andrea | Dir | — | $5.65M |
| Valantine Hannah | Dir | — | $4.37M |
| DANIELS RONALD J | Dir | — | $3.89M |
| Trimarchi Thomas | Pres, CFO | — | $3.03M |
| Scott Randal W. | Dir | — | $2.09M |
| Apuli Maricel | CAO | — | $621.7K |
Transactions 307
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-18 | 2021-11-16 | BBIO | STEPHENSON BRIAN C | See Remarks | F - Tax | $47.25 | -1,234 | 304.4K | -0.4% | -$58.3K |
| D | 2021-08-18 | 2021-08-16 | BBIO | Kumar Neil | CEO, Pres, Dir | F - Tax | $49.48 | -3,730 | 4.72M | -0.1% | -$184.6K |
| D | 2021-08-18 | 2021-08-16 | BBIO | Kumar Neil | CEO, Pres, Dir | M - OptEx | — | +7,523 | 4.72M | +0.2% | — |
| D | 2021-08-18 | 2021-08-16 | BBIO | STEPHENSON BRIAN C | See Remarks | M - OptEx | — | +2,487 | 304.2K | +0.8% | — |
| D | 2021-08-18 | 2021-08-16 | BBIO | STEPHENSON BRIAN C | See Remarks | F - Tax | $49.48 | -1,028 | 303.1K | -0.3% | -$50.9K |
| D | 2021-08-06 | 2021-08-04 | BBIO | SCHELLER RICHARD H | See Remarks, Dir | S - Sale+OE | $53.23 | -13.8K | 45.9K | -23% | -$733.3K |
| D | 2021-08-06 | 2021-08-04 | BBIO | SCHELLER RICHARD H | See Remarks, Dir | M - OptEx | $17.00 | +13.8K | 59.6K | +30% | +$234.2K |
Purchase Sale Sale after option exercise All abbreviations